Despite a Weak Quarter, DuPont Appears to Be Headed for Higher Ground
It was just a few weeks ago that E. I.DuPont , which has experienced its share of ups and downs, announced that its results for the second quarter would slip below the $1.28 per share it earned a year earlier. Coincidentally, that announcement followed by just a day news of a strong third quarter at Monsanto , the company that a restructuring DuPont is clearly seeking to emulate.
The primary question now becomes whether DuPont should be quarantined from Foolish portfolios, or constitutes a sensible long-term holding. The first thing to know in responding to that query is that the primary culprit for the disappointing quarter involves lower-than-expect corn seed sales, which the company called a "short-term trend."
Also having an impact, probably to no one's surprise, will be soft results from the performance chemicals unit, which is headed for a 2015 spinoff. On those bases, it's probable that a return of upward momentum isn't beyond the realm of possibility for the venerable company, which was formed as an explosives manufacturer way back in the Jefferson Administration.
You likely realize that DuPont is undergoing a major restructuring, moving from its longtime chemicals concentration to a greater weighting in agricultural, food products, and industrial biosciences. Last year, to make room and capital for that directional change, it sold its automotive paint unit for $5 billion and announced an agreement to sell a portion of its performance materials segment. As noted, it's also preparing to shed its erratic performance chemicals operation through a spinoff to DuPont shareholders.
As CEO Ellen Kullman pointed out at a Stanford Bernstein conference about a month ago, acquisitions during the same approximate period have included Danisco, a Danish producer of enzymes and specialty foods. In addition, about a year ago, DuPont bought a majority stake in Pannar Seed, the biggest seed producer on the African continent.
Agriculture's increasing share
For 2013, while Monsanto derived essentially all its revenues from agriculture-related products, DuPont's agriculture and biosciences sales accounted for a pro forma 57% of its total. As I've noted in the past, it appears likely that the group's contribution could reach 70% or more by 2016. In that connection, Kullman said at the Bernstein gathering that, "Market demand in this area is driven by both population growth and economic development, creating a myriad of needs and requirements among our customers."
For now, DuPont resembles an HGTV house in the throes of a serious renovation. Nevertheless, there are a couple of disparate ways to judge the company. Some are convinced that Kullman's promises have far outstripped DuPont's performance. Others, however, anticipate increasing valuations as the restructuring progresses. The corn problems that manifested themselves in the second quarter are likely temporary, and the company will clearly benefit from jettisoning its volatile performance chemicals segment.
A look at the numbers
While there's a bevy of legitimate question marks concerning DuPont's structure and composition, say, three years hence, it's enlightening for investors to examine some of the company's key current metrics. Let's compare a few of its numbers and ratios with those of Monsanto. And for added perspective, I'm inclined to include comparable metrics from Syngenta . While smaller than either DuPont or Monsanto, Basel, Switzerland-based Syngenta also produces herbicides, pesticides, seeds, and plants.
Return on Equity
Total Debt to Equity
Forward Annual Yield
As is clear, DuPont is of a similar size to Monsanto, with both topping Syngenta. Monsanto surpasses the others in the all-important P/E metric, and also leads handily from a margin perspective. While the returns on equity for all three are similar, DuPont produces the highest forward dividend yield. (From a trailing perspective, however, DuPont and Sygenta are about equal.)
The Foolish bottom line
Quarterly hiccup or not, then, I'm inclined to keep close tabs on DuPont. Once performance chemicals has been dispatched, the company's margins are likely to escalate meaningfully, which, in turn, will produce a salutary effect on its valuations. Having said that, I'd continue to reserve DuPont for investors with patience and longer-than-usual investment time horizons.
Warren Buffett just bought nearly 9 million shares of this company
Even amid our topsy-turvy world, agriculture stocks are likely to maintain a degree of stability. Ditto many energy names. I'm thinking of one in particular. Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report details this company that already has more than 50% market share. Just click HERE to discover more about this industry-leading stock... and join Buffett in his quest for a veritable landslide of profits!
The article Despite a Weak Quarter, DuPont Appears to Be Headed for Higher Ground originally appeared on Fool.com.David Smith has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.